CAR- T as well as mobile gene therapies are also costly

.Mother Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and also innovation transmission can supply cell genetics therapies at a cost effective price to patients across the world.